Consistent with an overall increase in tumor immunogenicity, SMAD4 mRNA had significant (FRD adjusted p value > 0.05) positive associations with CCL2, 4, 5, 8, 11, 14, 16, 17, 19, 21, 22, 23, and 25 (Table S3). Here, SMAD4 is linked to neoplasm.